Combination therapies with insulin in type 2 diabetes - PubMed (original) (raw)
Review
Combination therapies with insulin in type 2 diabetes
H Yki-Järvinen. Diabetes Care. 2001 Apr.
No abstract available
Similar articles
- Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus.
Tan K, Chow WS, Leung J, Ho A, Ozaki R, Kam G, Li J, Choi CH, Tsang MW, Chan N, Lee KK, Chan KW. Tan K, et al. Hong Kong Med J. 2019 Aug;25(4):312-319. doi: 10.12809/hkmj197802. Hong Kong Med J. 2019. PMID: 31416990 Review. No abstract available. - [Biphasic analog insulin instead of mixed insulin. Better adjustment, less hypoglycemia].
[No authors listed] [No authors listed] MMW Fortschr Med. 2003 Jun 12;145(24):56. MMW Fortschr Med. 2003. PMID: 12866308 German. No abstract available. - Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia?
Peacey SR, Robinson R, Bedford C, Harris ND, Macdonald IA, Holman RR, Heller SR. Peacey SR, et al. Diabetes Care. 2000 Jul;23(7):1022-3. doi: 10.2337/diacare.23.7.1022. Diabetes Care. 2000. PMID: 10895860 Clinical Trial. No abstract available. - Combination of insulin and metformin in the treatment of type 2 diabetes.
Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD. Wulffelé MG, et al. Diabetes Care. 2002 Dec;25(12):2133-40. doi: 10.2337/diacare.25.12.2133. Diabetes Care. 2002. PMID: 12453950 Clinical Trial. - Early use of insulin in type 2 diabetes.
Eldor R, Stern E, Milicevic Z, Raz I. Eldor R, et al. Diabetes Res Clin Pract. 2005 Jun;68 Suppl1:S30-5. doi: 10.1016/j.diabres.2005.03.004. Epub 2005 Mar 31. Diabetes Res Clin Pract. 2005. PMID: 15955372 Review.
Cited by
- Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes.
Meng Z, Xu C, Liu H, Gao X, Li X, Lin W, Ma X, Yang C, Hao M, Zhao K, Hu Y, Wang Y, Kuang H. Meng Z, et al. Front Endocrinol (Lausanne). 2023 Nov 2;14:1272112. doi: 10.3389/fendo.2023.1272112. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027146 Free PMC article. Clinical Trial. - Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.
Nauck MA, D'Alessio DA. Nauck MA, et al. Cardiovasc Diabetol. 2022 Sep 1;21(1):169. doi: 10.1186/s12933-022-01604-7. Cardiovasc Diabetol. 2022. PMID: 36050763 Free PMC article. Review. - Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes.
Yen FS, Wei JC, Lin MC, Hsu CC, Hwu CM. Yen FS, et al. BMC Endocr Disord. 2021 Feb 18;21(1):25. doi: 10.1186/s12902-021-00690-0. BMC Endocr Disord. 2021. PMID: 33602190 Free PMC article. - Network Patterns of Herbal Combinations in Traditional Chinese Clinical Prescriptions.
Wang N, Du N, Peng Y, Yang K, Shu Z, Chang K, Wu D, Yu J, Jia C, Zhou Y, Li X, Liu B, Gao Z, Zhang R, Zhou X. Wang N, et al. Front Pharmacol. 2021 Jan 20;11:590824. doi: 10.3389/fphar.2020.590824. eCollection 2020. Front Pharmacol. 2021. PMID: 33551800 Free PMC article. - Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
Song Y, Sui T, Zhang Y, Wang Y, Chen M, Deng J, Chai Z, Lai L, Li Z. Song Y, et al. Cell Mol Life Sci. 2020 Aug;77(16):3265-3277. doi: 10.1007/s00018-019-03354-4. Epub 2019 Nov 13. Cell Mol Life Sci. 2020. PMID: 31720743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical